Attitudes Towards PrEP and Anticipated Condom Use among Concordant HIV-Negative and HIV-Discordant Male Couples

AIDS Patient Care and STDs

Volumn 29, Issue 7, 2015, Pages 408-417

  Hoff, Colleen C ^a   Chakravarty, Deepalika ^a,b   Bircher, Anja E ^a   Campbell, Chadwick K ^a   Grisham, Kirk ^c   Neilands, Torsten B ^b   Wilson, Patrick A ^c   Dworkin, Shari ^d  

^a SAN FRANCISCO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Department of Medicine   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; AGED; ARTICLE; ATTITUDE ASSESSMENT; CHI SQUARE TEST; CLINICAL ARTICLE; CONDOM USE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LGBT PEOPLE; MALE; PRE-EXPOSURE PROPHYLAXIS; RACE; RISK ASSESSMENT; SEXUAL BEHAVIOR; ATTITUDE TO HEALTH; BEHAVIOR; CONDOM; ETHNOLOGY; FAMILY SIZE; HEALTH SURVEY; HIGH RISK BEHAVIOR; HIV INFECTIONS; INTERVIEW; MALE HOMOSEXUALITY; MIDDLE AGED; PATIENT ATTITUDE; PSYCHOLOGY; QUALITATIVE RESEARCH; SERODIAGNOSIS; SEXUALITY; STATISTICS AND NUMERICAL DATA; UNITED STATES; UTILIZATION;

ADULT; ANTI-HIV AGENTS; CONDOMS; FAMILY CHARACTERISTICS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HOMOSEXUALITY, MALE; HUMANS; INTENTION; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; NEW YORK CITY; PATIENT ACCEPTANCE OF HEALTH CARE; PRE-EXPOSURE PROPHYLAXIS; QUALITATIVE RESEARCH; RISK-TAKING; SAN FRANCISCO; SEXUAL BEHAVIOR; SEXUAL PARTNERS;

EID: 84934276465     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2014.0315     Document Type: Article

References (36)

1. CDC. Preexposure Prophylaxis for the Prevention of HIV Infection in the United States - 2014, A Clinical Practice Guideline. US Public Health Service. Available at http://www.cdc.gov/hiv/pdf/PrEPguidelines2014.pdf (Last accessed September 2, 2014).
2. World Health Organization. People most at risk of HIV are not getting the health services they need. http://www.who.int/mediacentre/news/releases/2014/key-populations-to-hiv/en/ (Last accessed September 4, 2014).
3. Karim SSA, Karim QA. Antiretroviral prophylaxis: A defining moment for HIV prevention. Lancet 2010;378:e23.
4. Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med 2012;367:423-434.
5. Baeten JM, Celum C. Antiretroviral pre-exposure prophylaxis for HIV-1 prevention among heterosexual African men and women: The Partners PrEP Study. Paper presented at: 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention, 2011.
6. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010;363:2587-2599.
7. Grant R, Anderson P, McMahon V, et al. Results of the iPrEx open-label extention (iPrEx OLE) in men and transgender women who have sex with men: PrEP uptake, sexual practices, and HIV incidence, Abstract #TUAC0105LB. International AIDS Conference. Melbourne, Australia, 2014.
8. Liu A, Vittinghoff E, Chillag K, et al. Sexual risk behavior among HIV-uninfected men who have sex with men (MSM) participating in a tenofovir pre-exposure prophylaxis (PrEP) randomized trial in the United States. J Acquir Immune Defic Syndr 2013;64:87-94.
9. Marcus JL, Glidden DV, Mayer KH, et al. No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis. PLoS ONE 2013;8:e81997.
10. Brooks R, Landovitz RJ, Kaplan RL, Lieber E, Lee S, Barkley TW. Sexual risk behaviors and acceptability of HIV Pre-Exposure Prophylaxis among HIV-negative gay and bisexual men in serodiscordant relationships: A mixed methods study. AIDS Patient Care STDS 2012;26:87-94.
11. Golub SA, Kowalczyk W, Weinberger C, Parsons J. Pre-exposure prophylaxis and predicted condom use among high-risk men who have sex with men. J Acquir Immune Defic Syndr 2010;54:548-555.
12. Tripathi A, Whiteside YO, Duffus WA. Perceptions and attitudes about preexposure prophylaxis among seronegative partners and the potential of sexual disinhibition. South Med J 2013;106:558-564.
13. Golub S. Tensions between the epidemiology and psychology of HIV risk: Implications for pre-exposure prophylaxis. AIDS Behav 2014;18:1686-1693.
14. Hosek S, Siberry G, Bell M, et al. Project PrEPare (ATN082): The acceptability and feasibility of an HIV pre-exposure prophylaxis (PrEP) trial with young men who have dex with men (YMSM). J Acquir Immune Defic Syndr 2013;62:447-456.
15. Campbell JD, Herbst JH, Koppenhaver RT, Smith DK. Antiretroviral prophylaxis for sexual and injection drug use acquisition of HIV. Am J Prev Med 2013;44:S63-S69.
16. Fuchs JD, Sobieszczyk ME, Madenwald T, et al. Intentions to use preexposure prophylaxis among current phase 2B preventive HIV-1 vaccine efficacy trial participants. J Acquir Immune Defic Syndr 2013;63:259-262.
17. Mantell JE, Sandfort TG, Hoffman S, Guidry JA, Masvawure TB, Cahill S. Knowledge and attitudes about preexposure prophylaxis (PrEP) among sexually active men who have sex with men and who participate in New York City Gay Pride events. LGBT Health 2014;1:93-97.
18. Krakower DS, Mimiaga MJ, Rosenberger JG, et al. Limited awareness and low immediate uptake of pre-exposure prophylaxis among men who have sex with men using an internet social networking site. PLoS ONE 2012;7:e33119.
19. Mimiaga MJ, Case P, Johnson CV, Safren SA, Mayer KH. Pre-Exposure Antiretroviral Prophylaxis (PrEP) attitudes in high risk Boston area MSM: Limited knowledge and experience, but potential for increased utilization after education. J Acquir Immune Defic Syndr 2009;50:77-83.
20. Holt M, Murphy D, Callander D, et al. HIV-negative and HIV-positive gay men's attitudes towards antiretroviral-based preventionsimilar attitudes to pre-exposure prophylaxis (PrEP) but greater scepticism among HIV-negative men about'treatment as prevention'. J Int AIDS Soc 2012;15:146-147.
21. Sineath RC, Finneran C, Sullivan P, et al. Knowledge of and interest in using pre-exposure prophylaxis for HIV prevention among men who have sex with men in Thailand. J Intl Assoc Providers AIDS Care 2013;12:227-231.
22. Mimiaga MJ, Closson EF, Kothary V, Mitty JA. Sexual partnerships and considerations for HIV antiretroviral pre-exposure prophylaxis utilization among high-risk substance using men who have sex with men. Arch Sex Behav 2014;43:99-106.
23. Saberi P, Gamarel KE, Neilands TB, et al. Ambiguity, ambivalence, and apprehensions of taking HIV-1 pre-exposure prophylaxis among male couples in San Francisco: A mixed methods study. PLoS ONE 2012;7, e50061.
24. Brooks R, Kaplan RL, Lieber E, Landovitz RJ, Lee S, Leibowitz AA. Motivators, concerns, and barriers to adoption of preexposure prophylaxis for HIV prevention among gay and bisexual men in HIV-serodiscordant male relationships. AIDS Care 2011;23:1136-1145.
25. Gamarel KE, Golub SA. Intimacy motivations and pre-exposure prophylaxis (PrEP) adoption intentions among HIV-negative men who have sex with men (MSM) in romantic relationships. Ann Behav Med 2015;49:177-186.
26. Denzin NK, Lincoln YS. The Landscape of Qualitative Research. 2nd ed. Thousand Oaks, CA: Sage, 2003.
27. Lindlof TR, Taylor BC. Qualitative Communication Research Methods. Thousand Oaks, CA: Sage, 2002.
28. Transana v2.23-MU [computer program]. Version 2.2x. Madison, WI: The Board of Regents of the University of Wisconsin System, 2007.
29. The White House Office of National AIDS Policy. National HIV/AIDS strategy for the United States: The White House Office of National AIDS Policy, 2010.
30. Gilmore HJ, Liu A, Koester KA, et al. Participant experiences and facilitators and barriers to pill use among men who have sex with men in the iPrEx pre-exposure prophylaxis trial in San Francisco. AIDS Patient Care STDS 2013;27:560-566.
31. Liu AY, Hessol NA, Vittinghoff E, et al. Medication adherence among men who have sex with men at risk for HIV infection in the United States: Implications for preexposure prophylaxis implementation. AIDS Patient Care STDS 2014;28:622-627.
32. McMahon JM, Myers JE, Kurth AE, et al. Oral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States: Opportunities and challenges. AIDS Patient Care STDS 2014;28:462-474.
33. Baeten JM, Grant R. Use of antiretrovirals for HIV prevention: What do we know and what don't we know? Curr HIV/AIDS Rep 2013;10:142-151.
34. Darbes LA. The 'bubble effect': Do men in relationships perceive themselves to be less at risk for HIV?. Contemporary Issues in Gay Men's Sexual Health Research Conference. San Juan, Puerto Rico, 2014.
35. CDC. HIV Among African American Gay and Bisexual Men. http://www.cdc.gov/hiv/risk/racialethnic/bmsm/facts/#refA (Last accessed August 3, 2014).
36. Campbell CK, Gómez AM, Dworkin S, et al. Health, trust, or "just understood": Explicit and implicit condom decision-making processes among Black, White, and interracial same-sex male couples. Arch Sex Behav 2014;43:697-706.